Pacer Advisors’s Celldex Therapeutics CLDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-680
| Closed | -$25.2K | – | 2564 |
|
|
2024
Q2 | $25.2K | Sell |
680
-210
| -24% | -$7.77K | ﹤0.01% | 3363 |
|
|
2024
Q1 | $37.4K | Buy |
+890
| New | +$37.4K | ﹤0.01% | 3289 |
|
|
2021
Q2 | – | Sell |
-2,828
| Closed | -$58K | – | 1439 |
|
|
2021
Q1 | $58K | Sell |
2,828
-828
| -23% | -$17K | ﹤0.01% | 1424 |
|
|
2020
Q4 | $64K | Buy |
+3,656
| New | +$64K | ﹤0.01% | 1398 |
|